Success Metrics

Clinical Success Rate
83.7%

Based on 169 completed trials

Completion Rate
84%(169/202)
Active Trials
50(16%)
Results Posted
50%(84 trials)
Terminated
33(11%)

Phase Distribution

Ph phase_3
73
24%
Ph not_applicable
17
6%
Ph phase_1
60
19%
Ph phase_4
5
2%
Ph phase_2
149
48%
Ph early_phase_1
4
1%

Phase Distribution

64

Early Stage

149

Mid Stage

78

Late Stage

Phase Distribution308 total trials
Early Phase 1First-in-human
4(1.3%)
Phase 1Safety & dosage
60(19.5%)
Phase 2Efficacy & side effects
149(48.4%)
Phase 3Large-scale testing
73(23.7%)
Phase 4Post-market surveillance
5(1.6%)
N/ANon-phased studies
17(5.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.5%

169 of 210 finished

Non-Completion Rate

19.5%

41 ended early

Currently Active

50

trials recruiting

Total Trials

309

all time

Status Distribution
Active(51)
Completed(169)
Terminated(41)
Other(48)

Detailed Status

Completed169
unknown47
Terminated33
Recruiting26
Active, not recruiting24
Withdrawn8

Development Timeline

Analytics

Development Status

Total Trials
309
Active
50
Success Rate
83.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (1.3%)
Phase 160 (19.5%)
Phase 2149 (48.4%)
Phase 373 (23.7%)
Phase 45 (1.6%)
N/A17 (5.5%)

Trials by Status

unknown4715%
suspended10%
withdrawn83%
active_not_recruiting248%
completed16955%
not_yet_recruiting10%
recruiting268%
terminated3311%

Recent Activity

Clinical Trials (309)

Showing 20 of 309 trialsScroll for more
NCT03418038Phase 2

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Recruiting
NCT00864318Phase 2

Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis

Completed
NCT02106988Phase 2

Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma

Active Not Recruiting
NCT02306161Phase 3

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

Active Not Recruiting
NCT02180867Phase 2

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Active Not Recruiting
NCT06230224Phase 3

A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma

Recruiting
NCT07477457Phase 2

A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

Recruiting
NCT05813327Phase 1

Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma

Active Not Recruiting
NCT07194044Phase 1

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

Recruiting
NCT03458260Phase 2

Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Completed
NCT05533775Phase 1

A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma

Recruiting
NCT04684368Phase 2

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Recruiting
NCT06647953Phase 3

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Recruiting
NCT04322318Phase 2

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Recruiting
NCT03007147Phase 3

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Active Not Recruiting
NCT01946529Phase 2

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Active Not Recruiting
NCT05991388Phase 2

A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

Recruiting
NCT04199026Not Applicable

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Recruiting
NCT06820957Phase 2

Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

Active Not Recruiting
NCT06528496Phase 2

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
309